Clinical trial

Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic…

NCT00149409 · Medical University of Vienna, Other · Completed

Key facts

NCT number NCT00149409
Title Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
Official title Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure:Effects On Endothelial Function, Left Ventricular Remodelling, Natriuretic Peptide Levels, And Exercise Capacity
Lead sponsor Medical University of Vienna, Other
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Chronic Heart Failure
Intervention type Dietary Supplement
Interventions Omacor
Start date Sep 1, 2005
Primary completion Feb 1, 2008
Completion Feb 1, 2008
First posted Sep 8, 2005
Last update posted Jul 13, 2010
Countries Austria

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies